Bacterial and Viral Infection and Sepsis: From Pathogenesis to Therapeutic Strategies
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 96625
Special Issue Editor
Special Issue Information
Dear Colleagues,
The growing interest in sepsis is associated with the recognition that it is, today, one of the most common and life-threatening conditions. According to recent studies, sepsis kills 11 million people each year, many of them children. Since bacterial infection is the main cause of sepsis, viral sepsis is often ignored, but the global spread of COVID-19 has changed the urgency. Importantly, platelet hyperactivity, thrombotic complication, and coagulopathy are relevant issues that can lead to multiple organ failure (MOF).
Timely diagnosis is essential to initiate effective treatment and to reduce the morbidity and mortality of sepsis. However, the diagnosis of sepsis remains a challenge, possibly related to the clinical complexity and dynamic characteristics of this disease. There is an enormous effort to investigate the pathophysiology of sepsis and the underlying mechanisms responsible for MOF in order to develop new biomarkers and early treatments in translational medical research.
We are looking forward to improving outcomes in sepsis. As such, this Special Issue of Biomedicines will focus on bacterial and viral sepsis and bring new insights into the genetics, pathophysiology, diagnosis, biomarkers, and treatment.
Prof. Dr. Giuseppe Montrucchio
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Viral and bacterial infection
- Sepsis
- Genetics
- Pathophysiology
- Platelet
- Biomarkers
- Multiple organ failure
- Current and future therapies
- Long COVID-19
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.